|
MMADHC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.65610000660388E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64669999858091E-09 |
| Normal-vs-Stage2 |
8.183500E-03 |
| Normal-vs-Stage3 |
6.305700E-02 |
| Normal-vs-Stage4 |
4.345400E-01 |
| Stage1-vs-Stage2 |
4.362000E-01 |
| Stage1-vs-Stage3 |
8.371700E-02 |
| Stage1-vs-Stage4 |
1.260370E-01 |
| Stage2-vs-Stage3 |
5.178400E-01 |
| Stage2-vs-Stage4 |
3.790200E-01 |
| Stage3-vs-Stage4 |
7.278000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28360000406502E-09 |
| Normal-vs-AfricanAmerican |
2.425000E-04 |
| Normal-vs-Asian |
5.793600E-01 |
| Caucasian-vs-AfricanAmerican |
3.412400E-01 |
| Caucasian-vs-Asian |
3.648800E-01 |
| AfricanAmerican-vs-Asian |
5.903000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.50339798574851E-11 |
| Normal-vs-Female |
6.698700E-03 |
| Male-vs-Female |
3.055700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.14699999999679E-05 |
| Normal-vs-Extreme_Weight |
2.44669839943867E-11 |
| Normal-vs-Obese |
5.64769999999992E-05 |
| Normal-vs-Extreme_Obese |
4.641800E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.245800E-01 |
| Normal_Weight-vs-Obese |
5.116600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.101000E-01 |
| Extreme_Weight-vs-Obese |
8.780100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.439600E-01 |
| Obese-vs-Extreme_Obese |
6.227800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.429600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.24809999954867E-07 |
| Normal-vs-Age(61-80Yrs) |
9.31460020225927E-10 |
| Normal-vs-Age(81-100Yrs) |
3.284300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.608200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.764220E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.884620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.931630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.415800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.344000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.18020038186728E-11 |
| Normal-VS-Type2 PRCC |
2.004600E-03 |
| Normal-VS-KIRP CIMP |
4.670000E-01 |
| Normal-VS-Unclassified PRCC |
3.963400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.842400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.963100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.342200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.495800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.908800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.396100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.36950000000503E-05 |
| Normal-vs-N1 |
9.627400E-01 |
| Normal-vs-N2 |
2.769800E-04 |
| N0-vs-N1 |
1.389960E-02 |
| N0-vs-N2 |
6.651400E-01 |
| N1-vs-N2 |
1.418750E-01 |
|
|
